Post-Exposure Prophylaxis (PEP) for HIV Guidelines
June 2023: The Third edition of the Post-Exposure Prophylaxis after Non-Occupational and Occupational Exposure to HIV: Australian National Guidelines is available. These guidelines outline the updated Australian recommendations for human immunodeficiency virus (HIV) post-exposure prophylaxis (PEP) following potential or known exposure to HIV in sexual, occupational, and non-occupational settings. Risk of transmission, the timing of […]
Clinical Auditing and Case Finding Fundamentals
Clinical Auditing and Case Finding Fundamentals is an eLearning course designed as an introduction to quality improvement (QI) and aims to support your understanding of the role and importance of QI within general practices. The module looks at the benefits of QI for the community, the practice and the patient, diving into fundamental principles and […]
Implementing long-acting injectable HIV PrEP: Recommendations to support the Australian health sector
On the 6th of April 2024, ASHM Health organised a national workshop, funded by ViiV Healthcare, to convene a select group of key stakeholders from each Australian state and territory. The primary objective was to facilitate discussions around how to successfully implement the use of long-acting injectable cabotegravir (CAB-LA) as HIV PrEP throughout Australia and to identify […]
Medications used for HIV Pre-Exposure Prophylaxis (PrEP) experiencing supply shortages in Australia
As of 9 September 2024, Australia is currently experiencing a supply shortage of medications containing tenofovir and emtricitabine, which are commonly used for HIV Pre-Exposure Prophylaxis (PrEP). Despite this shortage, pharmacists, HIV PrEP prescribers, and people using HIV PrEP should not be alarmed — shortages are expected to resolve later this year for most brands. Current impact […]
Budget announcement marks major investment in HIV, BBVs and STIs
ASHM welcomes news from the federal budget of a $126.5 million investment over two years to support the prevention, testing and treatment of blood-borne viruses (BBVs) and STIs, alongside a $43.9 million investment to implement the recommendations of the HIV Taskforce. This announcement represents a significant investment by the federal government in the national response […]
Preparing for PrEP in Papua New Guinea
Pre-Exposure Prophylaxis (PrEP) has been a game changer for HIV prevention. In Australia, biomedical HIV prevention strategies, including PrEP and treatment as prevention, have been instrumental in the significant declines in HIV transmission we have seen over the last ten years. However, rolling out a drug regime like PrEP can be complex. And while […]
Stigma and discrimination, no place in healthcare.
Stigma and discrimination, no place in healthcare. These resources serve as a guide and support for healthcare professionals seeking to understand and address the impact of stigma and discrimination on patient care. Our materials cover best practices for creating inclusive healthcare environments, identification and mitigation of bias, and relevant research and literature on the topic. […]
